These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
245 related items for PubMed ID: 8083959
1. The EBNA-2 arginine-glycine domain is critical but not essential for B-lymphocyte growth transformation; the rest of region 3 lacks essential interactive domains. Tong X, Yalamanchili R, Harada S, Kieff E. J Virol; 1994 Oct; 68(10):6188-97. PubMed ID: 8083959 [Abstract] [Full Text] [Related]
2. Residues 231 to 280 of the Epstein-Barr virus nuclear protein 2 are not essential for primary B-lymphocyte growth transformation. Harada S, Yalamanchili R, Kieff E. J Virol; 1998 Dec; 72(12):9948-54. PubMed ID: 9811732 [Abstract] [Full Text] [Related]
3. Epstein-Barr virus nuclear protein 2 is a critical determinant for tumor growth in SCID mice and for transformation in vitro. Cohen JI, Picchio GR, Mosier DE. J Virol; 1992 Dec; 66(12):7555-9. PubMed ID: 1331538 [Abstract] [Full Text] [Related]
4. An Epstein-Barr virus with a 58-kilobase-pair deletion that includes BARF0 transforms B lymphocytes in vitro. Robertson ES, Tomkinson B, Kieff E. J Virol; 1994 Mar; 68(3):1449-58. PubMed ID: 8107208 [Abstract] [Full Text] [Related]
5. P32/TAP, a cellular protein that interacts with EBNA-1 of Epstein-Barr virus. Wang Y, Finan JE, Middeldorp JM, Hayward SD. Virology; 1997 Sep 15; 236(1):18-29. PubMed ID: 9299613 [Abstract] [Full Text] [Related]
6. Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23. Wang F, Gregory C, Sample C, Rowe M, Liebowitz D, Murray R, Rickinson A, Kieff E. J Virol; 1990 May 15; 64(5):2309-18. PubMed ID: 2157887 [Abstract] [Full Text] [Related]
7. Epstein-Barr virus nuclear protein 2 mutations define essential domains for transformation and transactivation. Cohen JI, Wang F, Kieff E. J Virol; 1991 May 15; 65(5):2545-54. PubMed ID: 1850028 [Abstract] [Full Text] [Related]
13. oriP is essential for EBNA gene promoter activity in Epstein-Barr virus-immortalized lymphoblastoid cell lines. Puglielli MT, Woisetschlaeger M, Speck SH. J Virol; 1996 Sep 15; 70(9):5758-68. PubMed ID: 8709191 [Abstract] [Full Text] [Related]
14. EBNA-2 of herpesvirus papio diverges significantly from the type A and type B EBNA-2 proteins of Epstein-Barr virus but retains an efficient transactivation domain with a conserved hydrophobic motif. Ling PD, Ryon JJ, Hayward SD. J Virol; 1993 Jun 15; 67(6):2990-3003. PubMed ID: 8388484 [Abstract] [Full Text] [Related]
16. Delineation of the cis-acting element mediating EBNA-2 transactivation of latent infection membrane protein expression. Tsang SF, Wang F, Izumi KM, Kieff E. J Virol; 1991 Dec 15; 65(12):6765-71. PubMed ID: 1658373 [Abstract] [Full Text] [Related]
17. The domain of Epstein-Barr virus nuclear antigen 1 essential for binding to oriP region has a sequence fitted for the hypothetical basic-helix-loop-helix structure. Inoue N, Harada S, Honma T, Kitamura T, Yanagi K. Virology; 1991 May 15; 182(1):84-93. PubMed ID: 1850915 [Abstract] [Full Text] [Related]
18. Epstein-Barr virus nuclear antigen 3C putative repression domain mediates coactivation of the LMP1 promoter with EBNA-2. Lin J, Johannsen E, Robertson E, Kieff E. J Virol; 2002 Jan 15; 76(1):232-42. PubMed ID: 11739688 [Abstract] [Full Text] [Related]
20. An Epstein-Barr virus nuclear protein 2 domain essential for transformation is a direct transcriptional activator. Cohen JI, Kieff E. J Virol; 1991 Nov 15; 65(11):5880-5. PubMed ID: 1656076 [Abstract] [Full Text] [Related] Page: [Next] [New Search]